Intravenous omeprazole after endoscopy reduces rebleeding in patients with peptic ulcers [Classics Series]
Image: CC/L. academia
1. After endoscopic treatment, intravenous omeprazole significantly reduces the risk of rebleeding in patients with peptic ulcers at 3, 7, and 30 days
Original Date of Publication: August 3, 2000
Study Rundown: The findings of this trial demonstrate the value of a proton pump inhibitor in reducing the risk of rebleeding in patients with peptic ulcers. The fact that this study was carried out at a single centre in a predominantly Chinese population may limit the generalizability of the study. Moreover, the use of intravenous omeprazole is another concern, as it may not be available in certain other practice settings. Other studies, however, have demonstrated similar benefits with using orally administered proton pump inhibitors.
In sum, intravenous omeprazole reduces the risk of rebleeding in patients with bleeding peptic ulcers after endoscopic treatment.
EvidencePulse™by 2 Minute Medicine®
How does Intravenous omeprazole after endoscopy reduces rebleeding in patients with peptic ulcers apply to your patient?
Describe your patient and EvidencePulse weighs this trial against later evidence and current guidelines, with citations.
For a fuller review of the evidence, Deep research is a core feature of 2MM Max.
In-Depth [randomized controlled study]: This trial, published in 2000 in NEJM, sought to explore the value of intravenous omeprazole after endoscopy to reduce the risk of rebleeding in patients with peptic ulcers. After endoscopic treatment, bleeding peptic ulcers have been shown to rebleed in 15-20 percent of patients, though acid suppression may help stabilize clots and reduce the bleeding risk.
The trial was conducted at the Chinese University of Hong Kong. A total of 240 patients were randomized to receive either intravenous omeprazole (i.e., 80 mg bolus, then 8 mg/hour for 72 hours) or placebo after endoscopic treatment for bleeding peptic ulcers. Treatment with omeprazole significantly reduced the risk of recurrent bleeding at days 3, 7, and 30 compared to placebo. Moreover, omeprazole significantly reduced the length of hospitalization and blood transfusion requirements, though there were no significant differences in mortality between the two groups.
By Adrienne Cheung, Andrew Cheung, M.D.
Trials since this one
What later trials found on the same question.
- 2006
Ceftriaxone vs. norfloxacin for prophylaxis in patients with cirrhosis and gastrointestinal bleeding In The Classics
In cirrhotic patients who presented with gastrointestinal bleeding, patients treated with ceftriaxone were significantly less likely to develop proved or possible infections when compared to those treated with…
- 2007
Omeprazole before endoscopy in patients with gastrointestinal bleeding In The Classics
Compared to placebo, treating patients with omeprazole bolus and infusion prior to endoscopy significantly reduces the need for endoscopic therapy, the rate of post-endoscopy active bleeding, and shortens hospital stays.
3 more since 2000
2MM+ See every trial since Intravenous omeprazole after endoscopy reduces rebleeding in patients with peptic ulcers
2MM+ shows the full timeline of later trials on this question, with what each one found, and lets you save trials to reading lists for rounds, journal club and boards.
Citation: Lau JY, Sung JJ, Lee KK, Yung MY, Wong SK, Wu JC, et al. Effect of intravenous omeprazole on recurrent bleeding after endoscopic treatment of bleeding peptic ulcers. N Engl J Med. 2000 Aug 3;343(5):310-6. doi: 10.1056/nejm200008033430501. PMID: 10922420.
© 2013 2 Minute Medicine, Inc. All rights reserved. No part of this article may be reproduced, distributed or transmitted in any form or by any means without the prior written permission of 2 Minute Medicine, Inc. To license this content, contact 2 Minute Medicine, Inc. This article is for informational and educational purposes only; it is not medical advice and does not replace the judgment of a qualified healthcare professional.
Image: © 2 Minute Medicine
Get the app